Latest revenue
$150.6M
as of 2026-03-31
Latest net income
$-19.8M
as of 2026-03-31
Net margin
-13.1%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $7.06B
- Enterprise value
- $7.06B
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $148.11
- 52-wk low
- $73.16
- Beta
- —
- Shares out
- 58.7M
5-year trend
About GKOS
Business description and risk factors will appear here once GKOS's latest filing is fully ingested.
Profitability
Gross margin
55.7%
26.2%Operating margin
-39.3%
23.3%Net margin
-37.0%
3.1%Return on equity
-28.6%
49.9%Return on assets
-21.0%
39.9%Leverage
Debt / equity
0.36×
33.5%Long-term debt / equity
0.10×
14.6%Debt / assets
26.6%
24.6%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $150.6M | +41.2% | $-19.8M | -9.0% | -13.1% |
Q4 2025 2025-12-31 | $143.1M | +35.7% | $-133.7M | -298.0% | -93.4% |
Q3 2025 2025-09-30 | $133.5M | +38.1% | $-16.2M | +24.2% | -12.2% |
Q2 2025 2025-06-30 | $124.1M | +29.7% | $-19.7M | +61.1% | -15.8% |
Q1 2025 2025-03-31 | $106.7M | +24.6% | $-18.1M | +55.6% | -17.0% |
Q4 2024 2024-12-31 | $105.5M | — | $-33.6M | — | -31.8% |
Q3 2024 2024-09-30 | $96.7M | +23.9% | $-21.4M | +29.7% | -22.1% |
Q2 2024 2024-06-30 | $95.7M | +19.0% | $-50.5M | -54.0% | -52.8% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Surgical & Medical Instruments & Apparatus · SIC 3841
Your notes
Keep private notes on GKOS — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$46.7M
Net activity
−$46.7M
Distinct insiders
8
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns GKOS
Institutional value
$3.23B
Total shares held
30.5M
Distinct holders
214
-117 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 9.1M | $978.6M | -74.7K (-0.8%) | Trimmed |
| 2 | PRIMECAP MANAGEMENT CO/CA/ | 3.4M | $362.9M | -6.3K (-0.2%) | Trimmed |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.2M | $345.4M | — | New |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 2.5M | $270.1M | — | New |
| 5 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.1M | $115.6M | -33.1K (-3.0%) | Trimmed |
| 6 | Capital World Investors | 989.1K | $106.5M | +138.2K (+16.2%) | Added |
| 7 | Invesco Ltd. | 914.2K | $98.4M | +133.9K (+17.2%) | Added |
| 8 | Artisan Partners Limited Partnership | 607.5K | $65.4M | -95.4K (-13.6%) | Trimmed |
| 9 | JENNISON ASSOCIATES LLC | 487.0K | $52.4M | — | New |
| 10 | WESTFIELD CAPITAL MANAGEMENT CO LP | 482.2K | $51.9M | — | New |
| 11 | RIVERBRIDGE PARTNERS LLC | 433.2K | $46.6M | -101.9K (-19.0%) | Trimmed |
| 12 | Allspring Global Investments Holdings, LLC | 393.8K | $44.4M | +38.6K (+10.9%) | Added |
| 13 | Nuveen, LLC | 398.3K | $42.9M | -7.7K (-1.9%) | Trimmed |
| 14 | VANGUARD FIDUCIARY TRUST CO | 396.7K | $42.7M | — | New |
| 15 | UBS Group AG | 386.4K | $41.6M | -487.5K (-55.8%) | Trimmed |
| 16 | Capital International Investors | 373.3K | $40.2M | -138.2K (-27.0%) | Trimmed |
| 17 | Bank of New York Mellon Corp | 343.2K | $36.9M | -12.7K (-3.6%) | Trimmed |
| 18 | Champlain Investment Partners, LLC | 319.0K | $34.3M | -14.2K (-4.3%) | Trimmed |
| 19 | JPMORGAN CHASE & CO | 323.8K | $34.0M | -232.7K (-41.8%) | Trimmed |
| 20 | Clearbridge Investments, LLC | 286.1K | $30.8M | +174.0K (+155.4%) | Added |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once GKOS's latest filing finishes processing.